Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Ramelet, A.A.; | Boisseau, M.R. | Allegra, C. | Nicolaides, A. | Jaeger, K. | Carpentier, P. | Cappelli, R. | Forconi, S.
Affiliations: Angiologie & Dermatologie, Place Benjamin Constant 2, 1003 Lausanne, Switzerland | Université Victor Segalen Bordeaux 2, Département de Pharmacologie, 33076 Bordeaux, France | Department S.Giovanni Hospital, President UIP, Via S.Giovanni in Laterano 155, 00184 Rome, Italy | The Cyprus Institute of Neurology and Genetics, International Airport Avenue, 1683 Nicosia, Cyprus | Department of Angiology, University Hospital, Basel, CH-4031, Switzerland | Médecine Vasculaire, Hôpital Michallon, BP 217X, 38043 Grenoble cedex, France | Dipartimento di Medicina Interna, Cardiovascolare e Geriatrica, Università di Siena, Policlinico Santa Maria alle Scotte, Viale Bracci, 53100 Siena, Italy
Note: [] Corresponding author. Tel.: +41 21 312 60 60; Fax: +41 21 320 40 90; E-mail: aaramelet@hin.ch.
Abstract: Background: Veno-active drugs (VAD) have effects on edema and symptoms related to chronic venous disease (CVD), especially so-called venous pain. VAD's effectiveness, although well established, is regularly debated. Objective: Our purpose was to select all randomized controlled trials (RCTs) and meta-analyses devoted to VAD and symptoms in CVD, to submit them to a group of international experts in CVD and to vote with secrete ballot to determine the level of efficacy of each drug, according to EBM (Evidence-Based Medicine) rules and critical analysis. Methods: Publications in any language devoted to VAD and venous symptoms were searched for in different databanks and submitted to the experts prior to the meeting. Results: 83 papers were analyzed, including 72 RCTs or meta-analyses. Experts determined the level of EBM of each drug, according to the literature and personal experience, using 3 levels of recommendation, A, B and C (from large RCTs to non-randomized trials). Conclusions: VAD are effective and may be applied in CVD when symptomatic, from C0s to C6s. However, etiological treatment of venous reflux and venous hypertension has always priority. In some cases VAD may replace compression and/or complement its effects. If respecting these prerequisites, VAD are safe and effective.
Keywords: Chronic venous disease, edema, venous pain, veno-active drugs, consensus, evidence-based medicine
Journal: Clinical Hemorheology and Microcirculation, vol. 33, no. 4, pp. 309-319, 2005
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl